Total Payments
$160,449
2024 Payments
$5,515
Companies
23
Transactions
250
Medicare Patients
100
Medicare Billing
$20,556
Payment Breakdown by Category
Consulting$68,093 (42.4%)
Research$62,788 (39.1%)
Food & Beverage$10,419 (6.5%)
Travel$9,681 (6.0%)
Other$9,432 (5.9%)
Education$36.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $68,093 | 35 | 42.4% |
| Unspecified | $62,788 | 7 | 39.1% |
| Food and Beverage | $10,419 | 158 | 6.5% |
| Travel and Lodging | $9,681 | 44 | 6.0% |
| Honoraria | $6,000 | 2 | 3.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,432 | 2 | 2.1% |
| Education | $36.00 | 2 | 0.0% |
Payments by Type
General
$97,660
243 transactions
Research
$62,788
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ortho-Clinical Diagnostics, Inc. | $54,800 | 3 | $0 (2020) |
| Amgen Inc. | $42,765 | 65 | $0 (2021) |
| Abbott Laboratories | $14,540 | 89 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $12,875 | 10 | $0 (2022) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $9,396 | 5 | $0 (2023) |
| ABIOMED | $7,425 | 14 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $5,224 | 7 | $0 (2019) |
| Illumina, Inc. | $4,800 | 8 | $0 (2024) |
| AstraZeneca AB | $4,699 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,402 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,515 | 20 | Illumina, Inc. ($4,800) |
| 2023 | $11,369 | 21 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($5,753) |
| 2022 | $9,996 | 26 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($3,540) |
| 2021 | $8,982 | 33 | Abbott Laboratories ($4,606) |
| 2020 | $20,801 | 34 | Amgen Inc. ($7,552) |
| 2019 | $68,549 | 31 | Ortho-Clinical Diagnostics, Inc. ($47,600) |
| 2018 | $15,142 | 35 | Amgen Inc. ($10,811) |
| 2017 | $20,093 | 50 | Amgen Inc. ($9,595) |
All Payment Transactions
250 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Illumina, Inc. | Genetic Disease Research (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,716.00 | General |
| Category: Genetics | ||||||
| 11/22/2024 | Siemens Medical Solutions USA, Inc. | — | Food and Beverage | In-kind items and services | $88.94 | General |
| 11/15/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: Heart Failure | ||||||
| 11/11/2024 | Illumina, Inc. | Oncology Testing (Device) | Food and Beverage | Cash or cash equivalent | $123.79 | General |
| Category: Genetics | ||||||
| 11/11/2024 | Illumina, Inc. | Genetic Disease Testing (Device) | Food and Beverage | Cash or cash equivalent | $76.66 | General |
| Category: Genetics | ||||||
| 07/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $114.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/26/2024 | Eli Lilly and Company | — | Food and Beverage | Cash or cash equivalent | $110.61 | General |
| 06/26/2024 | Eli Lilly and Company | — | Travel and Lodging | Cash or cash equivalent | $77.99 | General |
| 06/20/2024 | Illumina, Inc. | Genetic Disease Testing (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,716.00 | General |
| Category: Genetics | ||||||
| 05/16/2024 | Illumina, Inc. | Genetic Disease Testing (Device) | Travel and Lodging | Cash or cash equivalent | $200.00 | General |
| Category: Genetics | ||||||
| 05/15/2024 | Illumina, Inc. | Genetic Disease Testing (Device) | Travel and Lodging | Cash or cash equivalent | $200.00 | General |
| Category: Genetics | ||||||
| 04/11/2024 | Illumina, Inc. | Genetic Disease Testing (Device) | Travel and Lodging | Cash or cash equivalent | $692.68 | General |
| Category: Genetics | ||||||
| 04/07/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $85.41 | General |
| Category: Heart Failure and Hypertension | ||||||
| 04/05/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $86.67 | General |
| 04/05/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $45.41 | General |
| 04/05/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $22.87 | General |
| 04/05/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $7.62 | General |
| 04/05/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $5.45 | General |
| 03/12/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $41.65 | General |
| Category: Heart Failure | ||||||
| 02/27/2024 | Illumina, Inc. | Genetic Disease Testing (Device) | Food and Beverage | Cash or cash equivalent | $75.07 | General |
| Category: Genetics | ||||||
| 11/20/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $442.50 | General |
| 11/11/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $86.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/10/2023 | ENDOTRONIX, INC. | CORDELLA PULOMONARY ARTERY PRESSURE SENSOR (Device) | Food and Beverage | Cash or cash equivalent | $49.75 | General |
| Category: HEART FAILURE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| NT-proBNP | Ortho-Clinical Diagnostics, Inc. | $54,800 | 3 |
| P4-AA Heart Failure Registry | Amgen Inc. | $4,500 | 1 |
| GALACTIC-HF | Amgen Inc. | $3,150 | 1 |
| BAY1067197 neladenoson bialanate PhIIb in HFrEF | Bayer HealthCare Pharmaceuticals Inc. | $320.43 | 1 |
| A STUDY OF LY3540378 IN PARTICIPANTS WITH WORSENING CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) | Eli Lilly and Company | $18.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 24 | 81 | $20,246 | $4,837 |
| 2021 | 2 | 31 | 66 | $26,540 | $6,889 |
| 2020 | 2 | 45 | 90 | $34,364 | $8,830 |
Total Patients
100
Total Services
237
Medicare Billing
$20,556
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 46 | $14,996 | $3,818 | 25.5% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2022 | 13 | 35 | $5,250 | $1,019 | 19.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 17 | 50 | $16,300 | $4,250 | 26.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 16 | $10,240 | $2,639 | 25.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 29 | 74 | $24,124 | $6,139 | 25.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 16 | 16 | $10,240 | $2,690 | 26.3% |
About Dr. David Lanfear, M.D
Dr. David Lanfear, M.D is a Cardiovascular Disease healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184792632.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Lanfear, M.D has received a total of $160,449 in payments from pharmaceutical and medical device companies, with $5,515 received in 2024. These payments were reported across 250 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($68,093).
As a Medicare-enrolled provider, Lanfear has provided services to 100 Medicare beneficiaries, totaling 237 services with total Medicare billing of $20,556. Data is available for 3 years (2020–2022), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Detroit, MI
- Active Since 12/01/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1184792632
Products in Payments
- Clinical Chemistry (Device) $54,800
- INVOKANA (Drug) $12,875
- Impella (Device) $7,425
- Circulatory Support (Device) $6,404
- XARELTO (Drug) $5,224
- Corlanor (Drug) $4,570
- HeartMate 3 Left Ventricular Assist Device (Device) $3,515
- Genetic Disease Testing (Device) $2,960
- Genetic Disease Research (Device) $1,716
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $1,632
- HeartMate 3 Left Ventricular Dev (Device) $1,259
- CardioMEMS HF System (Device) $975.86
- ENTRESTO (Drug) $563.10
- HeartMate (Device) $359.59
- Non-Covered $320.43
- LEQVIO (Drug) $263.14
- AORTIX SYSTEM (Device) $237.86
- HeartMate Touch (Device) $182.23
- HeartWare HVAD (Device) $180.48
- Confirm Rx (Device) $159.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Detroit
Dr. Tamam Mohamad
Cardiovascular Disease — Payments: $1.4M
Cardiovascular Disease $1.4M
Wayne Douglas Weaver, M.d, M.D
Cardiovascular Disease — Payments: $360,582
Cardiovascular Disease $360,582
Dr. Brian O'neill, M.d, M.D
Cardiovascular Disease — Payments: $182,193
Cardiovascular Disease $182,193
Dr. Brian Ference, Md, MD
Cardiovascular Disease — Payments: $160,503
Cardiovascular Disease $160,503
Dr. Mahir Elder, Md, MD
Cardiovascular Disease — Payments: $132,144
Cardiovascular Disease $132,144
Dr. Zaher Hakim, M.d, M.D
Cardiovascular Disease — Payments: $93,632
Cardiovascular Disease $93,632